Christopher Barden, Treventis CEO

Take­da joins forces with small pri­vate biotech for pre­clin­i­cal Alzheimer's re­search

Take­da is wad­ing deep­er in­to Alzheimer’s dis­ease re­search with a new pre­clin­i­cal col­lab­o­ra­tion an­nounced Tues­day.

The com­pa­ny will work with Treven­tis, a lit­tle-known pri­vate biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.